| AML | Acute Myeloid Leukemia |
| CR | Complete Response |
| CRc | Composite Complete Response |
| DLT | Dose-Limiting Toxicity |
| EFS | Event Free Survival |
| HSCT | Hematopoietic Stem Cell Transplant |
| OS | Overall Survival |
| RFS | Relapse Free Survival |
| AML | Acute Myeloid Leukemia |
| CR | Complete Response |
| CRc | Composite Complete Response |
| DLT | Dose-Limiting Toxicity |
| EFS | Event Free Survival |
| HSCT | Hematopoietic Stem Cell Transplant |
| OS | Overall Survival |
| RFS | Relapse Free Survival |